68
Views
1
CrossRef citations to date
0
Altmetric
METABOLIC MONITORING

Promoting physical health in youth mental health services: ensuring routine monitoring of weight and metabolic indices in a first episode psychosis clinic

(Research Fellow) , (Senior Research Fellow) , (Research Fellow) , (Team Leader) , (Research Fellow) , (Research Fellow) , (Medical Director) , (Professor of Youth Mental Health) & (Consultant Psychiatrist; Executive Director) show all
Pages 451-455 | Published online: 23 Sep 2010

REFERENCES

  • Grol R. Successes and failures in the implementation of evidence-based guidelines for clinical practice. Medical Care 2001; 39: II-46–II-54.
  • Killackey E, Jorm A, Alvarez-Jimenez M, McCann TV, Hides L, Couineau AL. Do we do what we know works, and if not why not? Australian & New Zealand Journal of Psychiatry 2008; 42: 439–444.
  • Grol R. Knowledge transfer in mental health care: how do we bring evidence into everyday practice? Canadian Journal of Psychiatry 2008; 53: 275–276.
  • Waterreus A, Laugharne JDE. Screening for the metabolic syndrome in patients receiving antisychotic treatment: a proposed algorithm. Medical Journal of Australia 2009; 190: 185–189.
  • Marder SR, Essock SM, Miller AL . Physical health monitoring of patients with schizophrenia. American Journal of Psychiatry 2004; 161: 1334–1349.
  • Álvarez-Jiménez M, Gonzalez-Blanch C, Vazquez-Barquero JL, Hetrick S, Rodriguez-Sanchez JM, Crespo-Facorro B. Antipsychotic-induced weight gain in schizophrenia spectrum disorders: a systematic critical reappraisal. CNS Drugs 2008; 22: 547–562.
  • Bick P, Knoesen N, Castle D. Clinical implications of the CATIE schizophrenia trials: day-to-day management lessons for Australasian psychiatrists. Australasian Psychiatry 2007; 15: 465–469.
  • Newcomer JW. Antipsychotic medications: metabolic and cardiovascular risk. Journal of Clinical Psychiatry 2007; 68: 8–13.
  • Newcomer JW. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs 2005; 19: 1–93.
  • Tschoner A, Engl J, Laimer M . Metabolic side effects of antipsychotic medication. International Journal of Clinical Practice 2007; 61: 1356–1370.
  • Hennekens CH. Increasing global burden of cardiovascular disease in general populations and patients with schizophrenia. Journal of Clinical Psychiatry 2007; 68: 4–7.
  • McGorry PD, Parker AG, Purcell R. Youth mental health services. InPsych Bulletin 2006; 2. Available from URL: http://www.psychology.org.au/publications/inpsych/youth_mental_health/
  • McGorry PD, Edwards J, Mihalopoulos C, Harrigan SM, Jackson HJ. EPPIC: An evolving system of early detection and optimal management. Schizophrenia Bulletin 1996; 22: 305–326.
  • McGorry PD, Parker AG, Purcell R. Youth mental health: a new stream of mental health care for adolescents and young adults. In: Meadows G, Singh B, Grigg M, Mental Health in Australia: Collaborative Community Practice, 2nd Cambridge: Cambridge University Press 2007; 438–449.
  • Lambert TJR, Chapman LH on behalf of the Consensus Working Group. Diabetes, psychotic disorders and antipsychotic therapy: a consensus statement. Medical Journal of Australia 2004; 181: 544–548.
  • National Research and Medical Research Council (NHMRC). How to Put Evidence into Practice: Implementation and Dissemination Strategies. Canberra: Commonwealth of Australia, 2000. Available from URL: http://www.nhmrc.gov.au/publications/synopses/_files/cp71.pdf.
  • Grimshaw JM, Thomas RE, MacLennan G . Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technology Assessment 2004; 8: iii-iv, 1–72.
  • Minichiello V, Aroni R, Timewell E, Alexander L. In-depth Interviewing: Principles, Techniques, Analysis, 2nd. Melbourne: Longman Australia, 1995.
  • Michie S, Johnston M, Abraham C, Lawton R, Parker D, Walker A. Making psychological theory useful for implementing evidence based practice: a consensus approach. Quality & Safety in Health Care 2005; 14: 26–33.
  • Braun V, Clarke V. Using thematic analysis in psychology. Qualitative Research in Psychology 2008; 3: 77–101.
  • Nasrallah HA, Newcomer JW. Atypical antipsychotics and metabolic dysregulation: evaluating the risk/benefit equation and improving the standard of care. Journal of Clinical Pharmacology 2004; 24: s7–s14.
  • Jamtvedt G, Young JM, Kristoffersen DT, O’Brien MA, Oxman A. Audit and feedback: effects on professional practice and health care outcomes. Cochrane Database of Systematic Reviews 2006; Issue 2.
  • Rege S. Antipsychotic induced weight gain in schizophrenia: mechanisms and management. Australian & New Zealand Journal of Psychiatry 2008; 42: 369–381.
  • Walter G, DeLaroche A, Soh N . Side effects of second generation antipsychotics: the experience, views and monitoring practices of Australian child psychiatrists. Australasian Psychiatry 2008; 16: 253–262.
  • Dunbar L, Brandt T, Wheeler A, Harrison J. Barriers and solutions to implementing metabolic risk assessment in a secondary mental health service. Australasian Psychiatry 2010; 18: 322–325.
  • Dunbar L, Wheeler A, Harrison J . Implementing metabolic risk assessment in a secondary care mental health service. Australasian Psychiatry 2010; 18: 318–321.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.